Bio Techne | TECH - Equity Capital And Reserves


Bio Techne reported $2.11B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio Techne USD 2.11B 22.92M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 2.44B 67M Jun/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Illumina USD 2.84B 162M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Merck EUR 30.17B 430M Jun/2026
Mettler Toledo International USD 12.82M 54.71M Jun/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Pacific Biosciences Of California USD -33.21M 35.58M Jun/2026
Repligen USD 2.11B 6.57M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Standard Biotools USD 561.12M 136.83M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 15.29B 12.73B Mar/2026